あすか製薬ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/07/05 | 2,403 | 2,428 | 2,400 | 2,419 | -3 | -0.1% | 42,000 |
2024/07/04 | 2,463 | 2,470 | 2,419 | 2,422 | -41 | -1.7% | 49,600 |
2024/07/03 | 2,475 | 2,492 | 2,446 | 2,463 | -12 | -0.5% | 51,100 |
2024/07/02 | 2,477 | 2,491 | 2,450 | 2,475 | -23 | -0.9% | 66,100 |
2024/07/01 | 2,500 | 2,550 | 2,484 | 2,498 | +17 | +0.7% | 84,400 |
2024/06/28 | 2,526 | 2,526 | 2,468 | 2,481 | -45 | -1.8% | 83,800 |
2024/06/27 | 2,632 | 2,636 | 2,526 | 2,526 | -156 | -5.8% | 155,700 |
2024/06/26 | 2,706 | 2,720 | 2,639 | 2,682 | +26 | +1% | 119,300 |
2024/06/25 | 2,600 | 2,660 | 2,570 | 2,656 | +149 | +5.9% | 145,500 |
2024/06/24 | 2,500 | 2,530 | 2,475 | 2,507 | +30 | +1.2% | 87,500 |
2024/06/21 | 2,447 | 2,480 | 2,440 | 2,477 | +48 | +2% | 103,600 |
2024/06/20 | 2,395 | 2,429 | 2,391 | 2,429 | +16 | +0.7% | 38,100 |
2024/06/19 | 2,431 | 2,439 | 2,393 | 2,413 | +21 | +0.9% | 49,700 |
2024/06/18 | 2,420 | 2,431 | 2,382 | 2,392 | -7 | -0.3% | 61,400 |
2024/06/17 | 2,410 | 2,422 | 2,377 | 2,399 | ±0 | ±0% | 52,600 |
2024/06/14 | 2,325 | 2,413 | 2,325 | 2,399 | +117 | +5.1% | 100,800 |
2024/06/13 | 2,331 | 2,360 | 2,278 | 2,282 | -61 | -2.6% | 50,500 |
2024/06/12 | 2,358 | 2,359 | 2,322 | 2,343 | -11 | -0.5% | 41,400 |
2024/06/11 | 2,324 | 2,361 | 2,324 | 2,354 | +45 | +1.9% | 44,500 |
2024/06/10 | 2,267 | 2,320 | 2,251 | 2,309 | +65 | +2.9% | 33,400 |
2024/06/07 | 2,258 | 2,258 | 2,200 | 2,244 | -19 | -0.8% | 53,800 |
2024/06/06 | 2,295 | 2,338 | 2,253 | 2,263 | -32 | -1.4% | 25,400 |
2024/06/05 | 2,328 | 2,400 | 2,287 | 2,295 | -1 | ±0% | 40,400 |
2024/06/04 | 2,327 | 2,338 | 2,290 | 2,296 | -40 | -1.7% | 46,100 |
2024/06/03 | 2,388 | 2,406 | 2,336 | 2,336 | -23 | -1% | 38,400 |
2024/05/31 | 2,319 | 2,369 | 2,281 | 2,359 | +65 | +2.8% | 45,300 |
2024/05/30 | 2,319 | 2,319 | 2,267 | 2,294 | -29 | -1.2% | 48,600 |
2024/05/29 | 2,377 | 2,395 | 2,295 | 2,323 | -37 | -1.6% | 64,000 |
2024/05/28 | 2,340 | 2,390 | 2,338 | 2,360 | +2 | +0.1% | 50,400 |
2024/05/27 | 2,287 | 2,358 | 2,287 | 2,358 | +80 | +3.5% | 56,900 |
2024/05/24 | 2,293 | 2,296 | 2,270 | 2,278 | -28 | -1.2% | 21,800 |
2024/05/23 | 2,310 | 2,318 | 2,262 | 2,306 | +46 | +2% | 50,400 |
2024/05/22 | 2,257 | 2,311 | 2,240 | 2,260 | +3 | +0.1% | 63,100 |
2024/05/21 | 2,282 | 2,320 | 2,251 | 2,257 | -27 | -1.2% | 45,400 |
2024/05/20 | 2,273 | 2,315 | 2,268 | 2,284 | +7 | +0.3% | 38,200 |
2024/05/17 | 2,266 | 2,308 | 2,256 | 2,277 | -25 | -1.1% | 37,000 |
2024/05/16 | 2,327 | 2,348 | 2,299 | 2,302 | -39 | -1.7% | 41,200 |
2024/05/15 | 2,450 | 2,450 | 2,330 | 2,341 | -103 | -4.2% | 66,400 |
2024/05/14 | 2,426 | 2,489 | 2,393 | 2,444 | -32 | -1.3% | 190,900 |
2024/05/13 | 2,400 | 2,534 | 2,319 | 2,476 | +393 | +18.9% | 434,200 |
2024/05/10 | 2,115 | 2,119 | 2,067 | 2,083 | -19 | -0.9% | 92,400 |
2024/05/09 | 2,112 | 2,128 | 2,100 | 2,102 | -15 | -0.7% | 77,300 |
2024/05/08 | 2,210 | 2,210 | 2,112 | 2,117 | -113 | -5.1% | 99,200 |
2024/05/07 | 2,252 | 2,261 | 2,230 | 2,230 | -37 | -1.6% | 57,600 |
2024/05/02 | 2,280 | 2,289 | 2,235 | 2,267 | -27 | -1.2% | 46,900 |
2024/05/01 | 2,315 | 2,325 | 2,283 | 2,294 | -35 | -1.5% | 22,500 |
2024/04/30 | 2,290 | 2,339 | 2,270 | 2,329 | +69 | +3.1% | 53,300 |
2024/04/26 | 2,258 | 2,270 | 2,219 | 2,260 | +2 | +0.1% | 45,100 |
2024/04/25 | 2,285 | 2,314 | 2,234 | 2,258 | -5 | -0.2% | 52,100 |
2024/04/24 | 2,240 | 2,270 | 2,233 | 2,263 | +24 | +1.1% | 38,400 |
201~
250
件表示中 / 1000件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
あすかHD | 229,600円 | +0.3% | +2.7% | 2.18% | 13.02倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
栄研化 | 222,200円 | +0.4% | -8.4% | 2.39% | 28.52倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 93,400円 | +22.8% | - | 0.00% | 76.31倍 | 1.23倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 49,400円 | -23.0% | - | 4.05% | - | 1.06倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ハートシード | 252,300円 | +174.2% | - | 0.00% | - | 8.59倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
市場注目の銘柄
チャート関連のコラム